Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
Journal of Patient-Reported Outcomes|February 5, 2022
To share or not to share: communication of caregiver-reported outcomes when a patient has colorectal cancerA Fuchsia Howard, María-José Torrejón, Kelsey Lynch, et al.
The Plant Journal : for Cell and Molecular Biology|September 5, 2020
Targeted mutation of barley (1,3;1,4)-β-glucan synthases reveals complex relationships between the storage and cell wall polysaccharide contentGuillermo Garcia-Gimenez, Abdellah Barakate, Pauline Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2017
Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor αCaitlin D Lowery, Wayne Blosser, Michele Dowless, et al.
The Plant Journal : for Cell and Molecular Biology|June 28, 2020
TERMINAL FLOWER-1/CENTRORADIALIS inhibits tuberisation via protein interaction with the tuberigen activation complexXing Zhang, Raymond Campbell, Laurence J M Ducreux, et al.
Development (Cambridge, England)|February 2, 2021
APETALA2 functions as a temporal factor together with BLADE-ON-PETIOLE2 and MADS29 to control flower and grain development in barleyJennifer R Shoesmith, Charles Ugochukwu Solomon, Xiujuan Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway SignalingMichele Dowless, Caitlin D Lowery, Terry Shackleford, et al.
Blood|February 16, 2023
Preclinical characterization of pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitorEliana B Gomez, Kevin Ebata, Hetal S Randeria, et al.
Pageof 21